Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

ZB004

Other · developed by Zenas BioPharma, LLC

Phase 1 Most advanced trial (none active)
ZBIO Developer
1 Registered trials

What is ZB004?

ZB004 is an investigational drug studied in Healthy Volunteers.

At a glance

Drug type
Other
Developer
Zenas BioPharma, LLC (ZBIO)
FDA status
Investigational, not approved in the US. Most advanced trial: Phase 1

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT05794516 Phase 1 Healthy Volunteers Completed ZBIO

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Healthy Volunteers

More from Zenas BioPharma, LLC

Sources

Updated Nov 1, 2026. Something wrong or missing? Report it on the ZBIO page.

Follow ZBIO, the company behind ZB004

See ZBIO's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

ZBIO catalysts and pipeline →
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.